↓ Skip to main content

Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin

Overview of attention for article published in Molecular Cancer, October 2007
Altmetric Badge

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin
Published in
Molecular Cancer, October 2007
DOI 10.1186/1476-4598-6-66
Pubmed ID
Authors

Larisa L Belyanskaya, Thomas M Marti, Sally Hopkins-Donaldson, Stefanie Kurtz, Emanuela Felley-Bosco, Rolf A Stahel

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 5%
Poland 1 2%
Unknown 38 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 27%
Student > Master 7 17%
Student > Bachelor 6 15%
Student > Ph. D. Student 5 12%
Other 3 7%
Other 3 7%
Unknown 6 15%
Readers by discipline Count As %
Agricultural and Biological Sciences 14 34%
Biochemistry, Genetics and Molecular Biology 11 27%
Pharmacology, Toxicology and Pharmaceutical Science 4 10%
Medicine and Dentistry 4 10%
Immunology and Microbiology 1 2%
Other 0 0%
Unknown 7 17%